FRUSCIO, ROBERT
FRUSCIO, ROBERT
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Evaluation of Human Papilloma Virus (HPV) Genotyping and Viral Load Determination as Diagnostic Biomarkers of Cervical Cancer Risk
2023 Martinelli, M; Giubbi, C; Saderi, L; Musumeci, R; Perdoni, F; Leone, B; Fruscio, R; Landoni, F; Piana, A; Sotgiu, G; Cocuzza, C
Borderline ovarian cancer
2022 Delle Marchette, M; Fruscio, R; Grassi, T; Paderno, M; Negri, S; Jaconi, M; Landoni, F
A comprehensive investigation of histotype-specific microRNA and their variants in stage I epithelial ovarian cancers
2022 Velle, A; Pesenti, C; Grassi, T; Beltrame, L; Martini, P; Jaconi, M; Agostinis, F; Calura, E; Katsaros, D; Borella, F; Fruscio, R; D'Incalci, M; Marchini, S; Romualdi, C
Gestational Intraplacental Choriocarcinoma in a Term Pregnancy: A Case Report
2022 Sala, A; Ornaghi, S; Delle Marchette, M; Bonazzi, C; Gorla, S; Moltrasio, F; Fruscio, R; Vergani, P; Landoni, F
Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study
2022 Fotopoulou, C; Khan, T; Bracinik, J; Glasbey, J; Abu-Rustum, N; Chiva, L; Fagotti, A; Fujiwara, K; Ghebre, R; Gutelkin, M; Konney, T; Ng, J; Pareja, R; Kottayasamy Seenivasagam, R; Sehouli, J; Surappa, S; Bhangu, A; Leung, E; Sundar, S; Fruscio, R
External Validation of the Ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors Into O-RADS Risk Groups
2022 Timmerman, S; Valentin, L; Ceusters, J; Testa, A; Landolfo, C; Sladkevicius, P; Van Holsbeke, C; Domali, E; Fruscio, R; Epstein, E; Franchi, D; Kudla, M; Chiappa, V; Alcazar, J; Leone, F; Buonomo, F; Coccia, M; Guerriero, S; Deo, N; Jokubkiene, L; Kaijser, J; Scambia, G; Andreotti, R; Timmerman, D; Bourne, T; Van Calster, B; Froyman, W
The risks of cancer in older women with BRCA pathogenic variants: How far have we come?
2022 Metcalfe, K; Gronwald, J; Tung, N; Mccuaig, J; Eisen, A; Elser, C; Foulkes, W; Neuhausen, S; Senter, L; Moller, P; Bordeleau, L; Fruscio, R; Velsher, L; Zakalik, D; Olopade, O; Eng, C; Pal, T; Cullinane, C; Couch, F; Kotsopoulos, J; Sun, P; Lubinski, J; Narod, S
Benign descriptors and ADNEX in two-step strategy to estimate risk of malignancy in ovarian tumors: retrospective validation on IOTA 5 multicenter cohort
2022 Landolfo, C; Bourne, T; Froyman, W; Van Calster, B; Ceusters, J; Testa, A; Wynants, L; Sladkevicius, P; Van Holsbeke, C; Domali, E; Fruscio, R; Epstein, E; Franchi, D; Kudla, M; Chiappa, V; Alcazar, J; Leone, F; Buonomo, F; Coccia, M; Guerriero, S; Deo, N; Jokubkiene, L; Savelli, L; Fischerova, D; Czekierdowski, A; Kaijser, J; Coosemans, A; Scambia, G; Vergote, I; Timmerman, D; Valentin, L
Evaluation of family history in individuals with heterozygous BRCA pathogenic variants diagnosed with breast or ovarian cancer in a single center in Italy
2022 Negri, S; De Ponti, E; Sina, F; Sala, E; Dell'Oro, C; Roversi, G; Lazzarin, S; Delle Marchette, M; Inzoli, A; Toso, C; Fumagalli, S; Campanella, M; Kotsopoulos, J; Fruscio, R
The Risks of Breast and Ovarian Cancer Associated with the Ashkenazi Jewish Founder Allele BRCA2 6174delT
2022 Finch, A; Metcalfe, K; Akbari, M; Friedman, E; Tung, N; Rosen, B; Eisen, A; Karlan, B; Foulkes, W; Neuhausen, S; Senter, L; Mckinnon, W; Elser, C; Sun, P; Narod, S; Fruscio, R
Impact of chemotherapy during pregnancy on fetal growth
2022 Maggen, C; Wolters, V; Van Calsteren, K; Cardonick, E; Laenen, A; Heimovaara, J; Mhallem Gziri, M; Fruscio, R; Duvekot, J; Painter, R; Masturzo, B; Shmakov, R; Halaska, M; Berveiller, P; Verheecke, M; de Haan, J; Gordijn, S; Amant, F
SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer
2022 Boria, F; Chiva, L; Chacon, E; Zanagnolo, V; Fagotti, A; Kucukmetin, A; Mom, C; Chakalova, G; Shamistan, A; Malzoni, M; Narducci, F; Arencibia, O; Raspagliesi, F; Toptas, T; Cibula, D; Kaidarova, D; Meydanli, M; Tavares, M; Golub, D; Perrone, A; Poka, R; Zusterzeel, P; Aluloski, I; Goffin, F; Haidopoulos, D; Haller, H; Jach, R; Yezhova, I; Bernardino, M; Bharathan, R; Maenpaa, M; Sukhin, V; Feron, J; Fruscio, R; Kukk, K; Ponce, J; Demirkiran, F; Vorgias, G; Povolotskaya, N; Coronado Martin, P; Marina, T; Zapardiel, I; Bizzarri, N; Gorostidi, M; Gutierrez, M; Manzour, N; Berasaluce, A
Copy number alterations in stage I epithelial ovarian cancer highlight three genomic patterns associated with prognosis
2022 Pesenti, C; Beltrame, L; Velle, A; Fruscio, R; Jaconi, M; Borella, F; Cribiu, F; Calura, E; Venturini, L; Lenoci, D; Agostinis, F; Katsaros, D; Panini, N; Bianchi, T; Landoni, F; Miozzo, M; D'Incalci, M; Brenton, J; Romualdi, C; Marchini, S
Targeted Mutational Analysis of Circulating Tumor DNA to Decipher Temporal Heterogeneity of High-Grade Serous Ovarian Cancer
2022 Paracchini, L; Mannarino, L; Beltrame, L; Landoni, F; Fruscio, R; Grassi, T; Dalessandro, M; D'Incalci, M; Marchini, S
Ultrasound features of endometrial pathology in women without abnormal uterine bleeding: results from the International Endometrial Tumor Analysis Study (IETA3)
2022 Heremans, R; Van den Bosch, T; Valentin, L; Wynants, L; Pascual, M; Fruscio, R; Testa, A; Buonomo, F; Guerriero, S; Epstein, E; Bourne, T; Timmerman, D; Leone, F
Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts
2022 Guffanti, F; Alvisi, M; Anastasia, A; Ricci, F; Chiappa, M; Llop-Guevara, A; Serra, V; Fruscio, R; Degasperi, A; Nik-Zainal, S; Bani, M; Lupia, M; Giavazzi, R; Rulli, E; Damia, G
Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation
2022 Xia, Y; Gronwald, J; Karlan, B; Lubinski, J; Mccuaig, J; Brooks, J; Moller, P; Eisen, A; Sun, S; Senter, L; Bordeleau, L; Neuhausen, S; Singer, C; Tung, N; Foulkes, W; Sun, P; Narod, S; Kotsopoulos, J; Yerushalmi, R; Fruscio, R; Rastelli, A; Zovato, S; Hyder, Z; Huzarski, T; Cybulski, C; Sweet, K; Wood, M; Mckinnon, W; Elser, C; Pal, T; Wiesner, G; Friedman, E; Meschino, W; Snyder, C; Metcalfe, K; Poll, A; Gojska, N; Warner, E; Kim, R; Rosen, B; Demsky, R; Ainsworth, P; Panabaker, K; Steele, L; Saal, H; Serfas, K; Panchal, S; Cullinane, A; Reilly, R; Blum, J; Kwong, A; Cybulski, C; Rayson, D; Isaacs, C; Ramón y Cajal, T; Dungan, J; Cohen, S
Tubal histopathological abnormalities in BRCA1/2 mutation carriers undergoing prophylactic salpingo-oophorectomy: a case-control study
2022 Sina, F; Cassani, C; Comerio, C; De Ponti, E; Zanellini, F; Delle Marchette, M; Roversi, G; Jaconi, M; Arbustini, E; Urtis, M; Dell'Oro, C; Zambetti, B; Paniga, C; Acampora, E; Negri, S; Lazzarin, S; Cesari, S; Spinillo, A; Kotsopoulos, J; Fruscio, R
Cancer Anxiety Mediates the Association Between Satisfaction With Medical Communication and Psychological Quality of Life After Prophylactic Bilateral Salpingo-Oophorectomy
2022 Zarbo, C; Brugnera, A; Frigerio, L; Celi, C; Compare, A; Dessì, V; Giordano, R; Malandrino, C; Sina, F; Strepparava, M; Tessitore, I; Ventura, M; Fruscio, R
Evaluation of BD Onclarity™ HPV Assay on Self-Collected Vaginal and First-Void Urine Samples as Compared to Clinician-Collected Cervical Samples: A Pilot Study
2022 Martinelli, M; Giubbi, C; Sechi, I; Bottari, F; Iacobone, A; Musumeci, R; Perdoni, F; Muresu, N; Piana, A; Fruscio, R; Landoni, F; Cocuzza, C